Detailed View
NGNE - Neurogene Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
710,231,168
Adj EBIT (TTM)
-110,758,000
Enterprise Value
467,062,168
Last Price
35.60
Earnings Yield
-23.71%
Return on Capital
-45.34%
Capital
244,275,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 0 | -33,349,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -27,530,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -23,798,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -26,081,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -25,919,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -21,512,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -22,180,000 |
| 2024-06-30 | 10-Q | 2024 | 925,000 | -20,134,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.